Impact Factor
4.20
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.18
9,322 total citations
h5-index
64
h5 depth signal
Cited share
83.9%
2,017 of 2,404
Total citations
9,322
Citation footprint
Metric signal
4.15
External metric anchor
Self-citation
1.2%
116 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
4,100
United States
2,082
Japan
808
Germany
324
Canada
321
Citing Fields of Research
Oncology
3,331
Liver & Colon Cancer
1,075
Immunology
1,045
Breast Cancer
980
Lung Cancer
896
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
9,726
Articles tracked across the journal lifetime
Indexed publication set
2,404
2,017 cited publications
Last 12 months
1,015
84.6 publications/month
Open access share
100.0%
1,015 OA publications in the last year
Leading citing country
China
4,100 citing publications
Leading citing field
Oncology
3,331 citing publications
Latest tracked publication
21 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Aug 2012-
v1n1, Aug 2012-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Immunology
Liver & Colon Cancer
Breast Cancer
Lung Cancer
Palliative Care
Broad Categories
Neoplasms
Palliative Care
Liver & Colon Cancer
Lung Cancer
Immunology
Digestive Disorders
Breast Cancer
Lymphomas
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/cam4.72393
Open DOI
Incidence, Mortality, and Survival Trends of Liver Cancer in the Canton of Zurich, Switzerland, Between 1980 and 2022
Background: The global burden of liver cancer has been increasing over recent decades, whereas the incidence in Switzerland has remained relatively stable. This study assessed long‐term trends in incidence, mortality, and 1‐ and 5‐year r...
02
DOI 10.1002/cam4.72352
Open DOI
Cyclopiane Suppresses Gastric Cancer Invasion and Angiogenesis via the CYR61 /αvβ3 Integrin/ NF ‐ κB Pathway
Background: Cysteine‐rich angiogenic inducer 61 (CYR61), a matricellular protein, has been implicated in gastric cancer aggressiveness through activation of integrin‐mediated NF‐κB signaling; however, effective pharmacological strategies...
03
DOI 10.1002/cam4.72269
Open DOI
Association of Primary Care Physician Density With Metastatic Cancer at Initial Diagnosis: A Population‐Based Study of 7 Cancers
Background: Patients with metastatic cancer at initial diagnosis have the worst prognosis. Despite their involvement in initial assessment, the relationship between Primary Care Physician availability and metastatic cancer at initial dia...
04
DOI 10.1002/cam4.72408
Open DOI
Survival Outcomes in Chronic Lymphocytic Leukemia During the Novel Agent Era: A Population‐Based Analysis
Chemoimmunotherapy (CIT) had long been used to treat chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) until 2014 when the first novel agent, ibrutinib, was approved in the United States. Numerous novel therapies have sin...
05
DOI 10.1002/cam4.72309
Open DOI
CDS2 Drives Tumor Progression in Epithelial Ovarian Cancer via the PI3K/AKT Pathway
Background: Epithelial ovarian cancer (EOC) frequently disseminates within the lipid‐rich peritoneal cavity, where tumor progression is accompanied by metabolic adaptations involving lipid utilization and mitochondrial function. Although...
06
DOI 10.1002/cam4.72365
Open DOI
Gene Therapy for Metastatic Castration‐Resistant Prostate Cancer Using the JC Polyomavirus ( JCPyV ) Virus‐Like Particles as a Gene Delivery Vector
Background: Systemic metastasis remains the leading cause of mortality in patients with advanced prostate cancer, particularly in castration‐resistant prostate cancer (CRPC), for which effective systemic therapeutic options are limited. ...
07
DOI 10.1002/cam4.72402
Open DOI
CBX4 and NOX4 Expression Are Associated With Chemoradiotherapy Response and Overall Survival in Locally Advanced Cervical Squamous Cell Carcinoma
Background: Tissue biomarkers may improve risk stratification in locally advanced cervical cancer before definitive concurrent chemoradiotherapy (CCRT). We evaluated pretreatment expression of chromobox 4 (CBX4), NADPH oxidase 4 (NOX4), ...
08
DOI 10.1002/cam4.72410
Open DOI
Impact of Organ‐Specific Severe Immune‐Related Adverse Events on Long‐Term Survival and Treatment Transitions in Metastatic Renal Cell Carcinoma: A 5‐Year Multicenter Multistate Analysis
Introduction: Immune‐related adverse events (irAEs) frequently occur during combination immune checkpoint inhibition. However, their prognostic impact may vary according to organ involvement and severity. In this study, we exploratorily ...
09
DOI 10.1002/cam4.72367
Open DOI
Integrated Spatial and Bulk Transcriptomic Analysis Identifies a Multicellular Ecosystem Involved in Progression of Young Breast Cancer
Young breast cancer (YBC), defined as diagnosis at or before the age of 40 years, is characterized by an aggressive phenotype and poor prognosis. The tumor microenvironment (TME), comprising immune and stromal cells, plays a critical rol...
10
DOI 10.1002/cam4.72313
Open DOI
Associations Between Circulating Metabolites and Skin Cancer: A Bidirectional Two‐Sample Mendelian Randomization Study
Background: Skin cancer is the most common type of cancer worldwide, categorized into melanoma and non‐melanoma types. While genetics play a crucial role in the development of skin cancer, recent developments in metabolomics have reveale...